Compare KraneShares CSI China Internet ETF (KWEB) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KraneShares CSI China Internet ETF vs DENTSPLY SIRONA Inc — how do they compare? KraneShares CSI China Internet ETF trades at $24.93 (market cap $4.37B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: KraneShares CSI China Internet ETF is far larger — about 2.5× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while KraneShares CSI China Internet ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold KraneShares CSI China Internet ETF for 57 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| KWEB | XRAY | |
|---|---|---|
Market Cap | $4.37B | $1.73B |
Volume | 13,393,361 | 6,198,582 |
Sector | Sector/Thematic | Health |
52-Week High | $41.35 | $14.68 |
52-Week Low | $23.63 | $8.52 |
Typical Hold Time | 57 Days | 72 Days |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KWEB trades at $24.93, up 2.47% today but maintains a bearish technical outlook with all 13 moving averages signaling sell. The ETF faces headwinds from China's economic challenges including industrial overcapacity and weak domestic consumption. Recent institutional activity shows mixed sentiment with Tidal Investments reducing its stake by 39.1% while HSBC increased its position by 27.7% in recent quarters.
The China internet ETF remains under pressure from geopolitical tensions and economic rebalancing concerns. While corporate profits surged 26% in Q2 2026, ongoing U.S.-China trade dynamics and potential export curbs create uncertainty. Technical indicators suggest continued bearish momentum with key support at $24.
DENTSPLY SIRONA (XRAY) trades at $8.83, down 3.4% with bearish technical signals. The stock faces fundamental challenges with negative net income margins (-14.99%) and declining revenue trends ($3.68B in 2025). Recent Q2 2026 earnings beat expectations but sales fell 4.1% amid ongoing turnaround efforts. The company maintains strong institutional interest despite hitting 52-week lows in September 2026.
XRAY presents a high-risk opportunity with Wall Street maintaining a cautious stance (37.5% buy rating). The consensus price target of $13.40 offers 52% upside potential, but investors face execution risks in the dental equipment turnaround, margin pressures, and competitive challenges. Near-term catalysts include management's presentation at the Baird Healthcare Conference in September 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
